Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,493 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Semiparametric models for cumulative incidence functions.
Bryant J, Dignam JJ. Bryant J, et al. Biometrics. 2004 Mar;60(1):182-90. doi: 10.1111/j.0006-341X.2004.00149.x. Biometrics. 2004. PMID: 15032788
Calculation of lytic units for the expression of cell-mediated cytotoxicity.
Bryant J, Day R, Whiteside TL, Herberman RB. Bryant J, et al. J Immunol Methods. 1992 Jan 21;146(1):91-103. doi: 10.1016/0022-1759(92)90052-u. J Immunol Methods. 1992. PMID: 1735786
Early stopping of a clinical trial when there is evidence of no treatment benefit: protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project.
Dignam JJ, Bryant J, Wieand HS, Fisher B, Wolmark N. Dignam JJ, et al. Control Clin Trials. 1998 Dec;19(6):575-88. doi: 10.1016/s0197-2456(98)00041-5. Control Clin Trials. 1998. PMID: 9875837 Clinical Trial.
Centralized medical monitoring in phase III clinical trials: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience.
Soran A, Nesbitt L, Mamounas EP, Lembersky B, Bryant J, Anderson S, Brown A, Passarello M. Soran A, et al. Clin Trials. 2006;3(5):478-85. doi: 10.1177/1740774506070747. Clin Trials. 2006. PMID: 17060221
Immunomodulatory function of interferon-gamma in patients with metastatic melanoma: results of a phase II-B trial in subjects with metastatic melanoma, ECOG study E 4987. Eastern Cooperative Oncology Group.
Kirkwood JM, Bryant J, Schiller JH, Oken MM, Borden EC, Whiteside TL. Kirkwood JM, et al. J Immunother. 1997 Mar;20(2):146-57. doi: 10.1097/00002371-199703000-00007. J Immunother. 1997. PMID: 9087387 Clinical Trial.
1,493 results
Jump to page
Feedback